207 related articles for article (PubMed ID: 29448247)
1. Knockdown of MAGEA6 Activates AMP-Activated Protein Kinase (AMPK) Signaling to Inhibit Human Renal Cell Carcinoma Cells.
Ye X; Xie J; Huang H; Deng Z
Cell Physiol Biochem; 2018; 45(3):1205-1218. PubMed ID: 29448247
[TBL] [Abstract][Full Text] [Related]
2. MAGEA6 promotes human glioma cell survival via targeting AMPKα1.
Pan SJ; Ren J; Jiang H; Liu W; Hu LY; Pan YX; Sun B; Sun QF; Bian LG
Cancer Lett; 2018 Jan; 412():21-29. PubMed ID: 29024810
[TBL] [Abstract][Full Text] [Related]
3. Lnc-THOR silencing inhibits human glioma cell survival by activating MAGEA6-AMPK signaling.
Xue J; Zhong S; Sun BM; Sun QF; Hu LY; Pan SJ
Cell Death Dis; 2019 Nov; 10(11):866. PubMed ID: 31727877
[TBL] [Abstract][Full Text] [Related]
4. microRNA-448 inhibits stemness maintenance and self-renewal of hepatocellular carcinoma stem cells through the MAGEA6-mediated AMPK signaling pathway.
Guo JC; Yang YJ; Zhang JQ; Guo M; Xiang L; Yu SF; Ping H; Zhuo L
J Cell Physiol; 2019 Dec; 234(12):23461-23474. PubMed ID: 31232474
[TBL] [Abstract][Full Text] [Related]
5. Bromodomain-Containing Protein 4 (BRD4) Inhibition Sensitizes Palomid 529-Induced Anti-Renal Cell Carcinoma Cell Activity in Vitro and in Vivo.
Xing ZY; Wang Y; Cheng L; Chen J; He XZ; Xing W
Cell Physiol Biochem; 2018; 50(2):640-653. PubMed ID: 30308518
[TBL] [Abstract][Full Text] [Related]
6. Activating AMP-activated protein kinase by an α1 selective activator compound 13 attenuates dexamethasone-induced osteoblast cell death.
Guo S; Mao L; Ji F; Wang S; Xie Y; Fei H; Wang XD
Biochem Biophys Res Commun; 2016 Mar; 471(4):545-52. PubMed ID: 26891866
[TBL] [Abstract][Full Text] [Related]
7. AMPK activation by ASP4132 inhibits non-small cell lung cancer cell growth.
Xia YC; Zha JH; Sang YH; Yin H; Xu GQ; Zhen J; Zhang Y; Yu BT
Cell Death Dis; 2021 Apr; 12(4):365. PubMed ID: 33824293
[TBL] [Abstract][Full Text] [Related]
8. miR-1273g silences MAGEA3/6 to inhibit human colorectal cancer cell growth via activation of AMPK signaling.
Wu F; Liu F; Dong L; Yang H; He X; Li L; Zhao L; Jin S; Li G
Cancer Lett; 2018 Oct; 435():1-9. PubMed ID: 30056111
[TBL] [Abstract][Full Text] [Related]
9. Role of SIRT1/AMPK signaling in the proliferation, migration and invasion of renal cell carcinoma cells.
Wang X; Lu Y; Tuo Z; Zhou H; Zhang Y; Cao Z; Peng L; Yu D; Bi L
Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33907836
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of MAGE-A6 enhanced the irradiation sensitivity of non-small cell lung cancer cells by activating the AMPK pathway.
Zhou J; Fan Q; Li J; Wu J; Huang J; Zhang Y; He X
Environ Toxicol; 2022 Jul; 37(7):1711-1722. PubMed ID: 35285568
[TBL] [Abstract][Full Text] [Related]
11. [Effects of SIPL1 screened by suppression subtractive hybridization (SSH) on biological function and drug resistance of renal cell carcinoma cells].
Li CY; Yao AM; Chang XN; Guo YH; Xu R
Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):897-903. PubMed ID: 24506958
[TBL] [Abstract][Full Text] [Related]
12. Ciclopirox olamine inhibits mTORC1 signaling by activation of AMPK.
Zhou H; Shang C; Wang M; Shen T; Kong L; Yu C; Ye Z; Luo Y; Liu L; Li Y; Huang S
Biochem Pharmacol; 2016 Sep; 116():39-50. PubMed ID: 27396756
[TBL] [Abstract][Full Text] [Related]
13. Targeting mTOR by CZ415 Inhibits Head and Neck Squamous Cell Carcinoma Cells.
Xie J; Li Q; Ding X; Gao Y
Cell Physiol Biochem; 2018; 46(2):676-686. PubMed ID: 29621758
[TBL] [Abstract][Full Text] [Related]
14. 6PGD Upregulation is Associated with Chemo- and Immuno-Resistance of Renal Cell Carcinoma via AMPK Signaling-Dependent NADPH-Mediated Metabolic Reprograming.
Cao J; Sun X; Zhang X; Chen D
Am J Med Sci; 2020 Sep; 360(3):279-286. PubMed ID: 32829780
[TBL] [Abstract][Full Text] [Related]
15. Itraconazole-Induced Inhibition on Human Esophageal Cancer Cell Growth Requires AMPK Activation.
Chen MB; Liu YY; Xing ZY; Zhang ZQ; Jiang Q; Lu PH; Cao C
Mol Cancer Ther; 2018 Jun; 17(6):1229-1239. PubMed ID: 29592879
[TBL] [Abstract][Full Text] [Related]
16. Underactivation of the adiponectin-adiponectin receptor 1 axis in clear cell renal cell carcinoma: implications for progression.
Kleinmann N; Duivenvoorden WC; Hopmans SN; Beatty LK; Qiao S; Gallino D; Lhotak S; Daya D; Paschos A; Austin RC; Pinthus JH
Clin Exp Metastasis; 2014 Feb; 31(2):169-83. PubMed ID: 24096711
[TBL] [Abstract][Full Text] [Related]
17. Long Non-Coding RNA MALAT1 Protects Human Osteoblasts from Dexamethasone-Induced Injury via Activation of PPM1E-AMPK Signaling.
Fan JB; Zhang Y; Liu W; Zhu XH; Xu DW; Zhao JN; Cui ZM
Cell Physiol Biochem; 2018; 51(1):31-45. PubMed ID: 30439702
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of ALPK2 blocks development and progression of renal cell carcinoma.
Jiang J; Han P; Qian J; Zhang S; Wang S; Cao Q; Shao P
Exp Cell Res; 2020 Jul; 392(2):112029. PubMed ID: 32330508
[TBL] [Abstract][Full Text] [Related]
19. Suppression of Tescalcin inhibits growth and metastasis in renal cell carcinoma via downregulating NHE1 and NF-kB signaling.
Luo AJ; Tan J; He LY; Jiang XZ; Jiang ZQ; Zeng Q; Yao K; Xue J
Exp Mol Pathol; 2019 Apr; 107():110-117. PubMed ID: 30594602
[TBL] [Abstract][Full Text] [Related]
20. Clusterin promotes growth and invasion of clear cell renal carcinoma cell by upregulation of S100A4 expression.
Liu Y; Men C; Xu Y; Zhao K; Luo L; Dong D; Yu Q
Cancer Biomark; 2018; 21(4):915-923. PubMed ID: 29400663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
